{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-26-006138","form_type":"8-K","ticker":"GWLL","cik":"0001800373","company_name":"GOLDENWELL BIOTECH, INC.","filed_at":"2026-10-09T13:50:45+00:00","discovered_at":"2026-10-09T13:52:00.221953+00:00","generated_at":"2026-10-12T15:15:32.991919+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Goldenwell Biotech adds Ming Zhou to board; CEO Shuang Liu gifts her 20.2% stake","bullets":["Board appointed Ming Zhou, 57, as a director on October 8, 2026; board now has four members: Shuang Liu, Yang Lee, Hua Xie and Zhou.","CEO Shuang Liu gifted 20,000,000 shares to Zhou the same day, equal to roughly 20.2% of Goldenwell's issued and outstanding common stock.","Zhou has been Managing Director of Get Health Co., Ltd. and Get Intertrading Co., Ltd. in Samutprakan, Thailand since 2021, covering health products, supplements and direct sales.","Zhou attended China Central Radio and TV University (now Open University of China) from 1991 to 1993, earning an Associate's Degree in Business Administration.","Company states no family relationships between Zhou and any director or officer, and no related-party transactions involving her since the start of the last fiscal year."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-26-006138","json":"https://secwatch.observer/filing/0001477932-26-006138.json","markdown":"https://secwatch.observer/filing/0001477932-26-006138.md","text":"https://secwatch.observer/filing/0001477932-26-006138.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1800373/000147793226006138/0001477932-26-006138-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1800373/000147793226006138/gdwl_8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T15:15:32.991919+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c7aa1ba479","claim":"Ming Zhou was appointed as director at GOLDENWELL BIOTECH, INC..","evidence_excerpt":"On October 8, 2026, the board of directors of Goldenwell Biotech, Inc. (the “Company”) appointed Ming Zhou as a director.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1800373/000147793226006138/0001477932-26-006138-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}